Mondelez India, Amway withdraw product claims after FSSAI notices
FSSAI said Mondelez India, Amway India and other food companies withdrew or revised product-label and advertising claims following regulatory notices. Mondelez removed claims from e-commerce platforms, while Amway will update XS packaging from its August 2026 production cycle.
What happened
FSSAI said Mondelez India, Amway India and other food firms withdrew or revised misleading product-label and advertising claims after regulatory notices.
Key facts
- 100%
- August 2026
Why this matters
Acquirers should intensify regulatory diligence on substantiation files, label claims and e-commerce content, since unresolved FSSAI exposure can create post-deal remediation liabilities.
What to watch
- Additional FSSAI notices naming other FMCG, nutraceutical, beverage or direct-selling brands.
- FSSAI guidance clarifying acceptable wording for nutrition, immunity, energy, weight-management or disease-adjacent claims.
- Marketplace policy changes requiring FSSAI documentation or approved label-image matching for health-related claims.
- Consumer complaints, competitor challenges or advertising-standard rulings over revised claims.
- Evidence of enforcement moving from withdrawal requests to fines, listing removals, product seizures or repeat-offender disclosures.
- Launch a cross-channel claims inventory covering packs, marketplace listings, quick-commerce pages, social content, influencer briefs and distributor materials.
- Create a substantiation matrix linking every claim to FSSAI-permitted language, scientific evidence, legal approval and current SKU artwork.
- Prioritize correction of high-traffic e-commerce pages before the next packaging production cycle; retain timestamped proof of removal and replacement.
- Add claim-governance gates to packaging artwork, product-information-management and campaign workflows.
- Prepare retailer and marketplace escalation protocols for third-party seller content that does not match approved brand claims.